À compter du 1er décembre 2023, l’accès à POEMs et à Essential Evidence Plus ne fera plus partie des avantages offerts aux membres de l’AMC.
Question clinique
Can swallowing a special sponge to sample esophageal epithelial cells for biomarker testing identify patients with Barrett's esophagus in primary care settings?
L’Essentiel
In this limited study, screening for Barrett's esophagus with a nurse-administered, office-based procedure was feasible in primary care settings and had a higher yield of Barrett's esophagus detection than usual care. 2b
Référence
Plan de l'etude: Randomized controlled trial (nonblinded)
Financement: Industry + govt
Cadre: Outpatient (primary care)
Sommaire
These researchers enrolled patients older than 50 years who had received prescriptions of histamine-2 receptor antagonists or proton pump inhibitors for at least 6 months in the previous year. They excluded patients who were concomitantly treated with nonsteroidal anti-inflammatory agents, those who had a known history of Barrett's esophagus, and those who had an upper endoscopy in the previous 5 years. The researchers randomized the patients to receive usual care (n = 6388) or office-based screening by a trained nurse (n = 6834). Usual care consisted of continued acid-suppression treatment and lifestyle advice or endoscopy referral according to the clinician's whims. The intervention consisted of swallowing a capsule containing a polyester mesh sphere (the Cytosponge) attached to a thread. After the patient swallows the capsule, the nurse yanks on the thread and pulls out the sponge and sends it for processing. In this case, the lab used a specific biomarker, trefoil factor 3 (TFF3), to identify the presence of intestinal metaplasia, and offered a referral for endoscopy if TFF3 was present. Of the 6834 patients invited to screening, only 2679 expressed interest: 1750 patients underwent the procedure, 96 (5.5%) were unable to swallow the capsule, and 231 had a positive TFF3 test result (10 of whom declined the endoscopy referral). A total of 311 (nearly 20%) of the patients had an equivocal negative result and were invited for a repeat procedure. Among the patients receiving usual care, 13 (< 1%) were given a diagnosis of Barrett's esophagus in the following year compared with 140 (2%) of the screened group. The absolute difference was 18.3 cases per 1000 person years. Four of the screened patients were found to have dysplasia and 5 had stage I esophageal cancer. One patient had to undergo endoscopy to rescue a sponge that separated from its thread; 89% of the patients felt the procedure was tolerable. Although the authors correctly identify Barrett's esophagus as a precancerous condition, they fail to report the incidence of cancer is low. So, more work is needed to see if patients who are screened for Barrett's esophagus in this manner are better off as a result.
Reviewer
Henry C. Barry, MD, MS
Professor
Michigan State University
East Lansing, MI
Commentaires
simple office procedure
It sounds like something the gastroenterologists will start using in the office before it spreads to family doctors.
WF5Ar3cIPE
UesbvYDyFGQjJb60ACdu